Empowerment and Overweight - a Prospective Observational Study (ADPB-EMPW)

June 6, 2013 updated by: Pierluigi Struzzo, MD, Azienda Per I Servizi Sanitari N. 2 Isontina

Th Efficacy of Individual Empowerment on Overweight and Obese Patients - a Prospective Observational Study.

Overweight and obesity put an heavy burden over people's health. Many methods are reported in medical literature but none of them proved to be effective in maintaining the results achieved over time. Motivational change remains a fundamental step towards the maintenance of a new lifestyle. Strengthening personal capabilities and self-esteem seem to be key strategies in motivating persons for change and facilitating a capacity of coping.

The aim of this study is to observe the effects of an individual empowerment program on the health of a group of overweight/obese persons.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

With this observational, uncontrolled prospective study we aim to observe any clinical modifications (concerning weight and other health indicators) achieved by a group of overweight and obese persons who underwent a therapy treatment by means of "self-empowerment".

The study will include all adults, with a Body Mass Index (BMI) above 25, entering the new "therapy groups" of the project, named "Diamo Peso al Benessere" ("Let's Give Weight to Well-Being") an NGO located within the Local Health Unit 4 Medio Friuli, Mental Health Department.

The added value of the strategy proposed by this association is relevant because it is mainly directed to the the improvement of the capacity building of each obese participant instead of focusing only to the food intake. General practice trainees will be dedicated to the evaluation and monitoring of the health status of a group of obese patients included into self-empowerment groups will be assessed for the following year. Major health indicators will be assessed: Body weight, height, waist circumference, brachial blood pressure (two measurements), non-invasive oxymetry.

Some questionnaires will be utilized: Antonovsky's sense of coherence scale, 10-point Likert scale about empowerment, Likert scale about perceived health, Berlin test, Hamilton rating scale for depression.

Blood tests will also be observed. Statistical Analysis A descriptive analysis of all the parameters collected, both the baseline data and those from the 6 and 12- month follow-ups.

For continuous variables (age, weight, BMI…) indicators will be calculated such as the mean, standard deviation, minimum, median and maximum values. The categorical data will be presented by means of frequency tables (n, %).

The changes in the parameters and in the distribution of categorical variables pertaining to the main and secondary outcomes will be assessed by comparing the baseline data collected and those from the 6 and 12-month follow-ups. McNemar's test will be used on the categorical variables, with a level of significance for the p-value fixed at < 0.05. This will allow to record any differences in the distributions of the main factors of interest. T-tests will be used for paired data for assessing changes in the categorical variables.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Udine, Italy, 33100
        • Dipartimento di Salute Mentale

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adult persons with BMI equal or above 25

Description

Inclusion Criteria:

- The study will include all adults, with a Body Mass Index (BMI) above 25, entering the new "therapy groups" of the project, named "Diamo Peso al Benessere" ("Let's Give Weight to Well-Being"), (Local Health Unit 4 Medio Friuli, Mental Health Department). Before being included in the therapy groups, persons will undergo three individual in-depth interviews with an empowerment consultant, with:

  • Verification of the motivation (Importance of the problem + Self-esteem, Likert scales 0 -10)
  • Request to underwrite the "therapy contract"
  • Final meeting for inclusion in the group and acquisition of informed consent.

Exclusion Criteria:

- minors will be excluded and

  • those who must shed weight in a short time because of planned surgery,
  • those who suffer from severe health problems (severe stroke outcomes, heart or kidney failure, neoplasia)
  • those who want to lose weight only for esthetic reasons,
  • those who cannot guarantee regular weekly attendance for the treatment,
  • those who also use other means for losing weight (weight-loss surgery, psychoanalysis, or other nutritional regimens).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Overweight, obese adult patients
Patients following a self empowerment group will be included in the study

1. Group meeting, introducing the method and the assessment tools

  1. Self-empowerment,
  2. Handing over the "journal",
  3. Questionnaire about emotional states and motivations for losing weight and for change.

The group meetings, lasting one hour and a half, will take place every week, always on the same day and at the same time, for one year. During each meeting the participant "weighs himself" and he notes his weight down in his journal.

Other Names:
  • self-empowerment
  • self-esteem

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decreasing body weight
Time Frame: 6,12 months
A persistent reduction of body weight is expected after 6 and 12 months
6,12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Improved blood pressure control
Time Frame: 6 and 12 months
6 and 12 months
decreasing glycemic levels
Time Frame: 6 and 12 months
6 and 12 months
decreasing total cholesterol values
Time Frame: 6 and 12 months
6 and 12 months
decreasing triglyceride values
Time Frame: 6 and 12 months
6 and 12 months
improvements in the creatinine levels
Time Frame: 6 and 12 months
6 and 12 months
stabilization and improvement of mood and temper (reduction in benzodiazepines and antidepressants)
Time Frame: 6 and 12 months
6 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierluigi Struzzo, MD, Regional Centre for the Training in Primary Care
  • Study Director: Mario Novello, MD, Azienda per i Servizi Sanitari Medio Friuli
  • Study Chair: Anita Cacitti, dr, Azienda per i Servizi Sanitari Medio Friuli

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

July 17, 2012

First Submitted That Met QC Criteria

July 18, 2012

First Posted (Estimate)

July 19, 2012

Study Record Updates

Last Update Posted (Estimate)

June 10, 2013

Last Update Submitted That Met QC Criteria

June 6, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CeformedDSM1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Self empowerment

3
Subscribe